Metraipolis › archive › dc_2732bdf30154

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers — Europe PMC PMID:42666522

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42666522
DOI
10.3389/fimmu.2026.1905617
License (as archived)
solo-consultazione
Archived
2026-10-16T13:45:57.651Z
SHA-256 of the archived text
c4a9a624370ba633c6ca2c1c6a59c9a19c3ad68b11a4394fee6f091b66996826
Stable URL of this page
https://metraipolis.com/documento/dc_2732bdf30154

How to cite

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers — Europe PMC PMID:42666522 — Europe PMC (en), https://europepmc.org/article/MED/42666522 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2732bdf30154 (Metraipolis archive dc_2732bdf30154, sha256 c4a9a624370ba633c6ca2c1c6a59c9a19c3ad68b11a4394fee6f091b66996826)
BibTeX
@misc{dc2732bdf30154,
  title = {Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers — Europe PMC PMID:42666522},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42666522},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2732bdf30154; sha256 c4a9a624370ba633c6ca2c1c6a59c9a19c3ad68b11a4394fee6f091b66996826},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666522. Agents can read the archived copy with the MCP tool read_document.